[1]
“The Association of HER-2 Over-expression in Relation to Hormonal Receptor Status and Common Clinico-pathological Parameters in Breast Carcinoma”, J. Surg. Sci., vol. 16, no. 2, pp. 59–67, Oct. 2019, doi: 10.3329/jss.v16i2.43602.